期刊文献+

LSD1、E-钙黏蛋白、N-钙黏蛋白在结肠癌中的表达及其意义 被引量:7

Expressions of LSD1,E-cadherin and N-cadherin in colon cancer and their significance
原文传递
导出
摘要 目的:探讨赖氨酸特异性组蛋白去甲基化酶1(LSD1)、E-钙黏蛋白(E-cad)、N-钙黏蛋白(N-cad)在结肠癌组织中的表达及其临床意义。方法:收集2006年2月—2008年12月于中南大学湘雅医院行手术切除的结肠癌标本108例,采用免疫组化技术检测结肠癌组织中LSD1、E-cad、N-cad的表达,并分析其与患者临床病理特征及预后的关系。结果:全组LSD1、E-cad、N-cad的阳性表率达分别为66.7%(72/108),85.2%例(92/108)、41.7%(45/108)。LSD1在较晚TNM分期、远处转移的结肠癌组织中的表达率明显增高,而E-cad则相反(均P<0.05),N-cad的表达在各项临床病理因素分组间差异均无统计学意义(均P>0.05)。LSD1与E-cad在结肠癌组织中的表达呈明显负相关(r=-0.318,P=0.001),与N-cad的表达无明显相关性(r=0.182,P=0.06)。LSD1的阳性表达组和E-cad的阴性表达组患者总生存率明显低于各自的阴性表达组与阳性表达组(均P<0.05),N-cad表达与否与患者总生存率无明显关系(P=0.410)。结论:LSD1和E-cad的表达与结肠癌的转移有密切关系,阳性表达LSD1和阴性表达E-cad的结肠癌预示预后不良。 Objective: To investigate the expressions of lysine-specific demethylase 1 (LSD 1), E-cadherin (E-cad) and N-cadherin (N-cad) in colon cancer and their clinical significance. Methods: Cancer tissue specimens from 108 cases of colon cancer who underwent operation at Xiangya hospital from February 2006 to December 2008 were collected, q-he expressions of LSDI, E-cad and N-cad in these colon cancer tissues were determined by immunohistochemical staining, and their relations with clinicopathologic characteristics and prognosis of the patients were analyzed. Results: In the entire group, the positive expression rate of LSD1, E-cad and N-cad in colon was 66.7% (72/108), 85.2% (92/108) and 41.7% (45/108), respectively. Positive LSD1 expression rate was significantly increased in tumors with advanced TNM stage and distant metastasis, which for E-cad was the opposite (all P〈0.05), while there were no statistical differences in N-cad expression among the groups divided according to clinicopathologic factors (all P〉0.05). In colon cancer tissues, the LSD1 expression was negatively correlated with E-cad expression (r=-0.318, P=0.001), but showed no significant correlation with N-cad expression (r=0.182, P=0.06). The overall survival rate in LSD 1 positive expression group and E-cad negative expression group was significantly lower than that in their respective negative expression group and positive expression group (both P〈O.05), while positive or negative N-cad expression yielded no significant relation with the overall survival of the patients (P=0.410).
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第4期462-467,共6页 China Journal of General Surgery
基金 国家自然科学基金资助项目(81302169 81360366) 贵州省科学技术基金资助项目(黔科合J字[2013]2178号)
关键词 结肠肿瘤 赖氨酸特异性组蛋白去甲基化酶1 钙黏着糖蛋白类 肿瘤转移 Colonic Neoplasms Lysine-Specific Demethylase i Cadherins Neoplasm Metastasis
  • 相关文献

参考文献15

  • 1Cui R, Okada Y, Jang SG, et al. Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population[J]. Gut, 2011, 60(6):799-805.
  • 2Lin T, Ponn A, Hu X, et al. Requirement of the histone demethylase LSD1 in Snai 1-mediated transcriptional repression during epithelial- mesenchymal transition[J]. Oncogene, 2010, 29(35):4896-4904.
  • 3Cho HS, Suzuki T, Dohmae N, et al. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells[J]. Cancer Res, 2011, 71 (3):655-660.
  • 4Lv T, Yuan D, Miao X, et al. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer[J]. PLoS One, 2012, 7(4):e35065.
  • 5Nenutil R, Smardova J, Pavlova S, et al. Discriminating functional and non-functional p53 in human tumors by p53 and MDM2 immunohistochemistry[J]. J Pathol, 2005, 207(3):251-259.
  • 6Shi Y, Lan F, Matsan C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD l[J]. Cell, 2004, 119(7):941-953.
  • 7Lee MG, Wynder C, Cocch N, et al. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation[J]. Nature, 2005, 437(7057):432-435.
  • 8Hayami S, Kelly JD, Cho HS, et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers[J]. Int J Cancer, 2011,128(3):574-586.
  • 9Bennani-Baiti Ibl, Maehado I, Llombart-Boseh A, et al. Lysine- specific demethylase 1 (LSDI/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosareoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma[J]. Hum Pathol, 2012, 43 (8): 1300-1307.
  • 10Huang J, Sengupta R, Espejo AB, et al. p53 is regulated by the lysine demethylase LSDI[J]. Nature, 2007, 449(7158):105-108.

二级参考文献26

  • 1Hal-DanWang,JunRen,LianZhang.CDH1 germline mutation in hereditary gastric carcinoma[J].World Journal of Gastroenterology,2004,10(21):3088-3093. 被引量:6
  • 2Thiery JP. Epithelial-mesenchymal transitions in tumor progression[ J]. Nat Rev Cancer,2002, 2(6) :442 -454.
  • 3Anthony J, Trimboli, Koichi F, et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer [ J ].Cancer Res,2008,68(3) :937 -945,.
  • 4Lee TK, Poon RT, Yuen AP, et al. Regulation of angiogenesis by ld- 1 through hypoxia- inducible factor- 1 alpha- mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma [ J ]. Clin Cancer Res, 2006, 12 (18) :5369 -5369.
  • 5Chaffer CL, Brennan JP, Slavin JL, et al. Mesenchymal to-epithelial transition facilitates bladder cancer metastasis role of fibroblast growth factor reptor-2 [ J ]. Cancer Res 2006, 66(23) :11271 - 11278.
  • 6Pena C, Garcia JM, Larriba MJ, et al. SNA11 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue [ J ]. Oncogcne, 2009, 28 ( 49 ) : 4375 -4385.
  • 7Hoshino Hi, Miyoshi No, Nagai K. Epithelial-mesenchymal transitions with expression of Snarl-induced chemoresistance in colorectal cancer [ J ]. BBRC, 2009, 390 (3) : 1061 - 1065.
  • 8Lame L, Bellcosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3, kinase/AKT pathway [ J ]. Oncogene, 2005, 24 (50) : 7442 -7454.
  • 9Huber MA, Kraut N, Beug H, et al. Molecular requirements for epithelial-mesenchymal transition during tumor progression [J]. Curr Opin Cell Biol,2005,17(5) :548 -558.
  • 10Evers EE, Zondag Gc, Mallin A, et al, Rho family proteins in cell adhesion and cell migration [ J ]. Eur J Cancer, 2000, 36(10) :1269 - 1274.

共引文献7

同被引文献50

  • 1Geng-WenHuang Lian-YueYang Wei-QunLu.Expression of hypoxia-inducible factor la and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival[J].World Journal of Gastroenterology,2005,11(11):1705-1708. 被引量:51
  • 2吴沛宏.肿瘤微创治疗展望[J].介入放射学杂志,2005,14(6):561-562. 被引量:6
  • 3高文龙,刘红林.DOT1——一类新的组蛋白赖氨酸甲基转移酶[J].遗传,2007,29(12):1449-1454. 被引量:6
  • 4Ana Cárdeno,Marina Sánchez-Hidalgo,M.Angeles Rosillo,CatalinaAlarcón de la Lastra.Oleuropein, a Secoiridoid Derived from Olive Tree, Inhibits the Proliferation of Human Colorectal Cancer Cell Through Downregulation of HIF-1α[J]. Nutrition and Cancer . 2013 (1)
  • 5GudrunKnechtel,JoannaSzkandera,MichaelStotz,GünterHofmann,UweLangsenlehner,PeterKrippl,HellmutSamonigg,WilfriedRenner,CordLangner,DadbehDehchamani,ArminGerger.Single nucleotide polymorphisms in the hypoxia‐inducible factor‐1 gene and colorectal cancer risk[J]. Mol. Carcinog. . 2010 (9)
  • 6Hyun-Soo Cho,Takehiro Suzuki,Naoshi Dohmae.Demethylation of RB Regulator MYPT1 by Histone Demethylase LSD1 Promotes Cell Cycle Progression in Cancer Cells. Cancer Research . 2011
  • 7Lin T,Ponn A,Hu X,Law B K,Lu J.Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncegene . 2010
  • 8FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.
  • 9LV T,YUAN D,MIAO X,et al.Over-expression of LSD1 promotes proliferation,migration and invasion in non-small cell lung cancer[J].PLo S One,2012,7(4):35065.
  • 10GOLDHIRSCH A,WINER E P,COATES A S,et al.Personalizing the treatment of women with early breast cancer:highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013[J].Ann Oncol,2013,24(9):2206-2223.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部